We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Latest Articles

The Coronavirus Outbreak
Article

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to the outbreak.

READ MORE

DNA Synthesis: Approaches, Advances and Applications
Article

In this article, we reflect on the state-of-the-art methods in writing DNA and leading directions for future DNA synthesis technology development.

READ MORE

Stay Up-to-Date With COVID-19 Drug Development
Article

Whilst the world waits for an effective COVID-19 vaccine to be developed, researchers are working tirelessly to design new drugs and repurpose existing drugs against the novel coronavirus SARS-CoV-2.

READ MORE

Keep Up-to-Date With COVID-19 Vaccine Development
Article

Technology Networks is committed to keeping you updated with the latest research in this space. In this article, you'll find a curation of our latest COVID-19 vaccine-related content.

READ MORE

A New Way To Characterize Glycans From SARS-CoV-2's Spike Protein
Article

Dr Rod Chalk, head of mass spectrometry at The Centre for Medicines Discovery (previously the Structural Genomics Consortium) has developed a novel mass spectrometry-based method for characterizing glycans from the Spike protein. In this interview, Chalk discusses the method and how it can be adopted in SARS-CoV-2 research and beyond.

READ MORE

How To Expedite Drug Development by Waiving Certain Clinical Trials
Article

The COVID-19 pandemic has caused numerous obstacles for clinical research across the world. Widespread movement restrictions, a diversion of healthcare personnel to the frontline and a compromised ability to ensure participant safety are examples of the many challenges faced by the pharmaceutical industry. But how can today’s pharma industry make progress and still get products to the market in the face of such long-term disruption? Is it possible to eliminate the need for human trials in some cases?

READ MORE

Transforming Drug Discovery Using AI and Automation
Article

The COVID-19 pandemic has unveiled a pressing issue – the need to develop effective drugs rapidly. But developing a new drug is easier said than done. Technologies such as microfluidics, robotics and the use of artificial intelligence, combined with automated data analysis, can expedite the drug development and approval process, helping make therapies available to patients more quickly.

READ MORE

AI Bridges Multiple Sclerosis Patients to Relevant Clinical Trials
Article

Clinical trials are a significant milestone in the development of innovative drugs and therapies for people diagnosed with different medical conditions including multiple sclerosis (MS). In this article, we examine how technology can make it easier for people to find and enroll on clinical trials.

READ MORE

COVID-19 Drug Discovery and Development – Why Diverse Strategies Are Critical
Article

We provide an update on ongoing global efforts to develop and test drugs for the treatment of COVID-19 and explore the range of strategies being employed.

READ MORE

Drug Repurposing Could Open the Door to New Therapies
Article

Drug discovery and development is expensive, time-consuming and complex. The estimated average cost of bringing a drug to market is now $2.6 billion; representing a 140 percent increase over the past ten years. That’s why today it is important for companies to explore new methods to reduce the discovery time frame. One approach that is proving productive is drug repurposing powered by artificial intelligence and machine learning.

READ MORE

 
Advertisement